StonvexLoading…
StonvexStonvexStonvexCore line items from RYAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.99B | $2.46B | $2.03B | $1.71B |
Operating Income | $493.64M | $427.81M | $359.08M | $289.51M |
Net Income | $63.40M | $94.67M | $61.04M | $61.05M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $10.56B | $9.65B | $7.25B | $6.38B |
Total Liabilities | $9.31B | $8.55B | $6.27B | $5.57B |
Cash & Equivalents | $158.32M | $540.20M | $838.79M | $992.72M |
Free Cash Flow OCF − CapEx | $575.71M | $467.87M | $447.43M | $320.47M |
Shares Outstanding | Not available | Not available | Not available | Not available |